Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 9 - The Artificial Womb

  • from Section 1: - General Principles
  • Edited by Mark D. Kilby, University of Birmingham, Anthony Johnson, Dick Oepkes
  • Book:
    Fetal Therapy
    Published online:
    21 October 2019
    Print publication:
    02 January 2020, pp 83-90

  • Summary

    Despite advances in neonatal intensive care, prematurity remains an unsolved clinical challenge and a leading cause of infant morbidity and mortality [1]. Approximately 6% of all live births in the USA are considered extremely preterm (delivery at less than 28 weeks’ gestation), and the incidence of prematurity has slowly risen over the past decade [2]. Prematurity is thought to account for one-third of infant mortality [3], one-half of cerebral palsy, and 80% of survivors born at 22–28 weeks’ gestation will suffer at least one major co-morbidity [4].